EFS revealed that IL-6, NGAL, and resistin are suitable markers for discrimination between AECOPD and CAP, and the discrimination was still possible with these selected features even when the CAP patient additionally suffers from COPD. The gene discussed is IL6; the disease is chronic obstructive pulmonary disease.